IL-8, whose levels are elevated in patients with CLL, has been shown to prime neutrophils to release NETs, thus suggesting a potential mechanism through which these cells may inadvertently support tumor progression while attempting to exert antimicrobial effects (121). This evidence concerns the gene CXCL8 and B-cell chronic lymphocytic leukemia.